Pure Global
NCT06421662

The Role of Attachment Training in Mother-infant Attachment

The Effect of Attachment Training Given to Pregnant Women on Mother Infant Attachment
Saglik Bilimleri Universitesi·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mother-Infant Interaction,Infant Development,Maternal Behavior
Drug/Device/Intervention
Attachment Training
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Saglik Bilimleri Universitesi
Location
Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Mar 04, 2024
Enrollment
60 participants
Primary outcome

Maternal Attachment

Summary

The study aimed to investigate the effect of attachment training given to pregnant women on
 mother-infant attachment.Primiparous pregnant women between 28.-38. weeks were randomized
 into two groups. Pregnant women in the study group were given attachment training for 15 days
 and the effect of the training on mother-infant attachment was investigated by using the
 mother-infant attachment scale at postpartum week 8 in comparison with the control group.

ICD-10 classifications
Fetus and newborn affected by other maternal conditionsFetus and newborn affected by other maternal noxious influencesFetus and newborn affected by unspecified maternal conditionFetus and newborn affected by maternal noxious influence, unspecifiedFetus and newborn affected by maternal conditions that may be unrelated to present pregnancy
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421662
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06421662 through Pure Global AI's free database. This phase not specified trial is sponsored by Saglik Bilimleri Universitesi and is currently Completed. The study focuses on Mother-Infant Interaction,Infant Development,Maternal Behavior. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.